Annual report pursuant to Section 13 and 15(d)

Balance Sheet

v3.21.1
Balance Sheet
Dec. 31, 2020
USD ($)
ASSETS  
Deferred offering costs $ 165,778
TOTAL ASSETS 165,778
Current liabilities  
Accrued offering costs 140,778
Promissory note — related party 5,000
Total Current Liabilities 145,778
Commitments and Contingencies
Shareholders’ Equity  
Preference shares, $0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding
Additional paid-in capital 24,367
Accumulated deficit (5,000)
Total Shareholders’ Equity 20,000
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY 165,778
Class A ordinary shares  
Shareholders’ Equity  
Ordinary shares, value
Class B ordinary shares  
Shareholders’ Equity  
Ordinary shares, value 633 [1]
Total Shareholders’ Equity $ 633
[1] Included an aggregate of up to 825,000 Class B ordinary shares that were subject to forfeiture depending on the extent to which the underwriters’ over-allotment option was exercised. On January 14, 2021, the Company effected a share capitalization of 575,000 shares and, as a result, there are 6,325,000 founder shares issued and outstanding. All share and per share amounts have been retroactively restated to reflect the share capitalization (see Note 3).